Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
253.2500 -2.15 (-0.84%)
NSE Dec 04, 2025 11:43 AM
Volume: 7,405
 

253.25
-0.84%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 15.2% YoY to | 257.4 crore (I-direct estimate: | 269.4 crore) mainly due to 18.4% YoY growth in export formulations to | 92.3 crore (I-direct estimates: | 115.6 crore). Domestic formulations grew 12.7% to | 142.1 crore (I-direct estimate: | 130.6 crore) EBITDA margins declined 238 bps YoY to 16.2% (I-direct estimate of 17.9%) mainly on account of an increase in employee expenditure...
Indoco Remedies Ltd. is trading below all available SMAs
More from Indoco Remedies L…
All earning calls
Investor presentations from Indoco Remedies L…
All investor presentations